Moreau P, Attal M, Hulin C, et al. Phase 3 randomized study of daratumumab + bortezomib/thalidomide/dexamethasone (D-VTD) versus VTD in transplant-eligle newly diagnosed multiple myeloma: part 1 CASSIOPEIA results. 24th Congress of EHA, abstract S145.
Slimme beeldvorming om celtherapie te verbeteren
mei 2024 | Immuuntherapie, Leukemie, Lymfoom